DS
About
David Segarra, CEO: MBA from IESE Business School and University of California Berkeley, Master of Science in Engineering from Barcelona Tech (UPC) and Master in Business Biotechnology. Has been co-founder and CEO of Aptus Biotech (therapeutic and diagnostic applications based on aptamer technology), Igen biotech (development and marketing of Genetic and Epigenetic kits for clinical use); partner and advisor of investing platform Growth Factor Biocapital. Has also been advisor of medical institutions on innovation strategies.
Position in the VCSift Database
- • 3 investors at AptaTargets are tracked.
- • 3,360 investors hold the CEO role in VCSift. David Segarra is one of them.
- • 930 investors are based in Madrid, Madrid, Spain.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Madrid, Spain
Contact Information
linkedin.com/in/••••••••
Find more investors like David
Search Investors